“Philadelphia is Leading a Biotech Revolution.” That’s the headline of an article by Senior Editor Gary Daughters in the May issue of Site Selection magazine. The Chamber is using the piece to share news of the region’s leadership role in the cell & gene therapy sector and highlight the momentum underway in the life sciences industry. John Fry, President, Drexel University; Sumit Verma, Senior Vice President of Commercial Manufacturing, Iovance; and Mahen Gundecha, Chief Business Officer, Exegenesis Bio, all share insights into the key attributes of Greater Philadelphia that make it an attractive destination for companies looking to locate and expand in the region.
The magazine quotes Fry: “We think Philadelphia is the center of the country for cell & gene therapy. We have built an environment here to welcome companies who want to be where all this began. We’re building new capacity, and we have the talent to support new companies.”
In addition to sharing the article with site selectors, the Chamber distributed the article to attendees at the recent 2022 BIO International Conference held June 13-16 in San Diego, CA.